!Series_title	"RNA-seq analysis of human heart failure"
!Series_geo_accession	"GSE55296"
!Series_status	"Public on Apr 28 2014"
!Series_submission_date	"Feb 24 2014"
!Series_last_update_date	"Apr 27 2022"
!Series_pubmed_id	"24599027"
!Series_pubmed_id	"25137373"
!Series_pubmed_id	"25884818"
!Series_pubmed_id	"31009519"
!Series_pubmed_id	"29667349"
!Series_pubmed_id	"27041589"
!Series_pubmed_id	"26710323"
!Series_pubmed_id	"28934278"
!Series_pubmed_id	"29320567"
!Series_pubmed_id	"27936202"
!Series_pubmed_id	"27481317"
!Series_pubmed_id	"31554869"
!Series_pubmed_id	"34829621"
!Series_pubmed_id	"35052814"
!Series_pubmed_id	"35453616"
!Series_summary	"The goal of this study is to compare the transcriptome of heart failure patients (with ischemic or dilated cardiomyopathy) undergoing heart transplantation compared with healthy controls."
!Series_overall_design	"We analyzed 36 human samples. 13 from ischemic and 13 from dilated human hearts compared with 10 healthy control donors."
!Series_type	"Expression profiling by high throughput sequencing"
!Series_contributor	"Estefanía,,Tarazón"
!Series_contributor	"Esther,,Roselló-Lletí"
!Series_contributor	"Ana,,Ortega"
!Series_contributor	"Maria,M,Molina-Navarro"
!Series_contributor	"Juan,C,Triviño"
!Series_contributor	"Francisca,,Lago"
!Series_contributor	"José,R,González-Juanatey"
!Series_contributor	"Placido,,Orosa"
!Series_contributor	"José,A,Montero"
!Series_contributor	"Antonio,,Salvador"
!Series_contributor	"Manuel,,Portolés"
!Series_contributor	"Miguel,,Rivera"
!Series_sample_id	"GSM1333746 GSM1333747 GSM1333748 GSM1333749 GSM1333750 GSM1333751 GSM1333752 GSM1333753 GSM1333754 GSM1333755 GSM1333756 GSM1333757 GSM1333758 GSM1333759 GSM1333760 GSM1333761 GSM1333762 GSM1333763 GSM1333764 GSM1333765 GSM1333766 GSM1333767 GSM1333768 GSM1333769 GSM1333770 GSM1333771 GSM1333772 GSM1333773 GSM1333774 GSM1333775 GSM1333776 GSM1333777 GSM1333778 GSM1333779 GSM1333780 GSM1333781 "
!Series_contact_name	"Estefanía,Tarazón,Melguizo"
!Series_contact_institute	"Health Research Institute La Fe"
!Series_contact_address	"Avenida Fernando Abril Martorell, 106"
!Series_contact_city	"Valencia"
!Series_contact_state	"Valencia"
!Series_contact_zip/postal_code	"46026"
!Series_contact_country	"Spain"
!Series_supplementary_file	"ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE55nnn/GSE55296/suppl/GSE55296_count_data.txt.gz"
!Series_platform_id	"GPL16288"
!Series_platform_taxid	"9606"
!Series_sample_taxid	"9606"
!Series_relation	"BioProject: https://www.ncbi.nlm.nih.gov/bioproject/PRJNA239241"
!Series_relation	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRP038887"

!Sample_title	"Ischemic rep1"	"Dilated rep1"	"Ischemic rep2"	"Control rep1"	"Ischemic rep3"	"Control rep2"	"Control rep3"	"Control rep4"	"Control rep5"	"Ischemic rep4"	"Dilated rep2"	"Control rep6"	"Ischemic rep5"	"Ischemic rep6"	"Ischemic rep7"	"Ischemic rep8"	"Control rep7"	"Ischemic rep9"	"Ischemic rep10"	"Dilated rep3"	"Ischemic rep11"	"Dilated rep4"	"Dilated rep5"	"Ischemic rep12"	"Control rep8"	"Control rep9"	"Dilated rep6"	"Dilated rep7"	"Control rep10"	"Ischemic rep13"	"Dilated rep8"	"Dilated rep9"	"Dilated rep10"	"Dilated rep11"	"Dilated rep12"	"Dilated rep13"
!Sample_geo_accession	"GSM1333746"	"GSM1333747"	"GSM1333748"	"GSM1333749"	"GSM1333750"	"GSM1333751"	"GSM1333752"	"GSM1333753"	"GSM1333754"	"GSM1333755"	"GSM1333756"	"GSM1333757"	"GSM1333758"	"GSM1333759"	"GSM1333760"	"GSM1333761"	"GSM1333762"	"GSM1333763"	"GSM1333764"	"GSM1333765"	"GSM1333766"	"GSM1333767"	"GSM1333768"	"GSM1333769"	"GSM1333770"	"GSM1333771"	"GSM1333772"	"GSM1333773"	"GSM1333774"	"GSM1333775"	"GSM1333776"	"GSM1333777"	"GSM1333778"	"GSM1333779"	"GSM1333780"	"GSM1333781"
!Sample_status	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"	"Public on Apr 28 2014"
!Sample_submission_date	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"	"Feb 24 2014"
!Sample_last_update_date	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"	"May 15 2019"
!Sample_type	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"	"SRA"
!Sample_channel_count	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"	"1"
!Sample_source_name_ch1	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"	"Heart"
!Sample_organism_ch1	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"	"Homo sapiens"
!Sample_characteristics_ch1	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"	"tissue: Left ventricular tissue"
!Sample_characteristics_ch1	"disease state: ischemic"	"disease state: dilated"	"disease state: ischemic"	"disease state: healthy"	"disease state: ischemic"	"disease state: healthy"	"disease state: healthy"	"disease state: healthy"	"disease state: healthy"	"disease state: ischemic"	"disease state: dilated"	"disease state: healthy"	"disease state: ischemic"	"disease state: ischemic"	"disease state: ischemic"	"disease state: ischemic"	"disease state: healthy"	"disease state: ischemic"	"disease state: ischemic"	"disease state: dilated"	"disease state: ischemic"	"disease state: dilated"	"disease state: dilated"	"disease state: ischemic"	"disease state: healthy"	"disease state: healthy"	"disease state: dilated"	"disease state: dilated"	"disease state: healthy"	"disease state: ischemic"	"disease state: dilated"	"disease state: dilated"	"disease state: dilated"	"disease state: dilated"	"disease state: dilated"	"disease state: dilated"
!Sample_treatment_protocol_ch1	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."	"Transmural samples were taken from near the apex of the left ventricle and stored at 4°C for a maximum of 6 h from the time of coronary circulation loss. Samples were stored at -80°C until the RNA and protein extractions were performed."
!Sample_molecule_ch1	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"
!Sample_extract_protocol_ch1	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."	"Heart samples were homogenized with TRIzol® agent in a TissueLysser LT (Qiagen, UK). All RNA extractions were performed using a PureLink™ Kit according to the manufacturer’s instructions (Ambion Life Technologies, CA). RNA was quantified using a NanoDrop1000 spectrophotometer (Thermo Fisher Scientific, UK) and the purity and integrity of RNA samples was measured using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano LabChip kit (Agilent Technologies, Spain). All samples displayed a 260/280 ratio greater than 2.0 and RNA integrity numbers ≥ 9."
!Sample_extract_protocol_ch1	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."	"Total PolyA-RNA samples were used to generate whole transcriptome libraries for sequencing on the SOLiD 5500XL platform, following the manufacturer’s recommendation (Life Technologies, CA). No RNA-spike in controls was used. Amplified cDNA quality was analyzed by the Bioanalyzer 2100 DNA 1000 kit (Agilent Technologies, Spain) and quantified using the Qubit 2.0 Fluorometer (Invitrogen, UK). The whole transcriptome libraries were used for making SOLiD templated beads following the SOLiD Templated Bead Preparation guide. Bead quality was estimated based on WFA (workflow analysis) parameters. The samples were sequenced using the 50625 paired-end protocol, generating 75 nt + 35 nt (Paired-End) + 5 nt (Barcode) sequences. Quality data were measured using software SETS parameters (SOLiD Experimental Tracking System)."
!Sample_taxid_ch1	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"	"9606"
!Sample_description	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"	"total RNA"
!Sample_data_processing	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"	"Bioscope mapping software version 1.3"
!Sample_data_processing	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"	"Hg19 Homo Sapiens genome. Low quality sequences filter"
!Sample_data_processing	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"	"Htseq-count algorithms for gene counts (Htseq software version 0.5.4p3)"
!Sample_data_processing	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"	"Differential expression using EdgeR method version 3.2.4"
!Sample_data_processing	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"	"Genome_build: Hg19 Homo Sapiens"
!Sample_platform_id	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"	"GPL16288"
!Sample_contact_name	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"	"Estefanía,Tarazón,Melguizo"
!Sample_contact_institute	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"	"Health Research Institute La Fe"
!Sample_contact_address	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"	"Avenida Fernando Abril Martorell, 106"
!Sample_contact_city	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"
!Sample_contact_state	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"	"Valencia"
!Sample_contact_zip/postal_code	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"	"46026"
!Sample_contact_country	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"	"Spain"
!Sample_data_row_count	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"	"0"
!Sample_instrument_model	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"	"AB 5500xl Genetic Analyzer"
!Sample_library_selection	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"	"cDNA"
!Sample_library_source	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"	"transcriptomic"
!Sample_library_strategy	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"	"RNA-Seq"
!Sample_relation	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650866"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650867"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650863"	"Reanalyzed by: GSE81474"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650869"	"Reanalyzed by: GSE81474"	"Reanalyzed by: GSE81474"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650874"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650873"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650870"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650875"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650872"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650871"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650877"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650885"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650878"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650886"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650888"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650880"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650882"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650876"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650887"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650881"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650879"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650893"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650895"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650883"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650884"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650897"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650889"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650891"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650896"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650894"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650892"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650898"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650890"
!Sample_relation	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475380"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475381"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475382"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650865"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475384"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650864"	"BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN02650868"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475387"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475388"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475389"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475390"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475391"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475392"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475393"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475394"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475395"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475396"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475397"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475398"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475399"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475400"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475401"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475402"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475403"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475404"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475405"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475406"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475407"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475408"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475409"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475410"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475411"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475412"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475413"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475414"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475415"
!Sample_relation	""	""	""	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475383"	""	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475385"	"SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX475386"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
!Sample_supplementary_file_1	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"	"NONE"
!series_matrix_table_begin
"ID_REF"	"GSM1333746"	"GSM1333747"	"GSM1333748"	"GSM1333749"	"GSM1333750"	"GSM1333751"	"GSM1333752"	"GSM1333753"	"GSM1333754"	"GSM1333755"	"GSM1333756"	"GSM1333757"	"GSM1333758"	"GSM1333759"	"GSM1333760"	"GSM1333761"	"GSM1333762"	"GSM1333763"	"GSM1333764"	"GSM1333765"	"GSM1333766"	"GSM1333767"	"GSM1333768"	"GSM1333769"	"GSM1333770"	"GSM1333771"	"GSM1333772"	"GSM1333773"	"GSM1333774"	"GSM1333775"	"GSM1333776"	"GSM1333777"	"GSM1333778"	"GSM1333779"	"GSM1333780"	"GSM1333781"
!series_matrix_table_end
